The EBRD is investing €3.6 million to strengthen the Croatian pharmaceutical packaging producer Piramida d.o.o. and in plans to expand the company’s production. While €2.7 million will be used for balance sheet restructuring, the remaining €0.9 million will finance additional production facilities.

Piramida, established in 1950 serves mainly the markets of former Yugoslavia, and today is the regional leader in manufacturing ampoules and vials for the pharmaceutical industry. The company generates over 90 per cent of its sales from exports.

Despite steady growth over the past years the company has identified significant growth potential which Piramida is aiming to address with an ambitious investment programme during the period 2012-2016 to replace or replenish the current production facilities which were constructed in the 1980s. The investment programme includes the extension of the production hall, the acquisition of additional production lines and the installation of state-of-the-art technology to boost output.

Piramida was privatised in 2001 and acquired by Blue Sea Capital, a fund incorporated in the Netherlands with offices in Croatia and Serbia investing in mid-sized companies in former Yugoslavia, in July 2012.

Frederic Lucenet, the EBRD Director for Manufacturing and Services said: “We are pleased with the opportunity to strengthen the development of a strong and competitive local company by fostering its potential to grow with our investment. We are impressed with the quality of Piramida’s products and are confident that the modernisation of its production facilities will create the capacity for successful expansion into lucrative new markets.”

“One of the reasons we acquired Piramida was for its growth potential in supplying pharmaceutical companies throughout Europe. Since the acquisition, we embarked on a large expansion programme in order to be able to satisfy demand for Piramida’s products. We are happy to receive the financial support of EBRD in this project, providing us with the appropriate financing for the expansion” said Sasa Galic, Managing Partner at Blue Sea Capital.

“This investment will mark a change in our production facilities. Modernisation and extension of the production plant and introduction of new ampoules and vials lines will enable Piramida to create a competitive advantage, providing greater reliability and flexibility to our customers” said Kresimir Hlede, CEO of Piramida.

The EBRD loan to Piramida is being arranged under the EBRD Local Enterprise Facility, an investment instrument providing long-term financing to small and medium-sized enterprises in the Western Balkans, Turkey and the SEMED region (Egypt, Jordan, Morocco and Tunisia). It provides a wide range of flexible financial products to companies, whose needs are not sufficiently addressed by existing financing sources.
Jevremova provides a large number of patients and families access to top quality medical care by a team of experts in the field of gynaecology, obstetrics and IVF.

Sasa Galic, Managing Partner of Blue Sea Capital, said: “This transaction, our second investment in the health care sector in Serbia, sees Blue Sea Capital start its planned process of the consolidation of providers offering good quality and accessible medical care in the country. We are very pleased to be entering into this partnership with the formidable team of professionals at Jevremova.”

Vuk Vukovic, Partner at Blue Sea Capital, added: “We are very happy to continue our work with the management of both institutions, Dr Ristic, our first healthcare acquisition, and Jevremova, on the further development of the private health care sector in Serbia, and to support the expansion of the only private maternity ward in the country.”
Jevremova provides a large number of patients and families access to top quality medical care by a team of experts in the field of gynaecology, obstetrics and IVF.

Sasa Galic, Managing Partner of Blue Sea Capital, said: “This transaction, our second investment in the health care sector in Serbia, sees Blue Sea Capital start its planned process of the consolidation of providers offering good quality and accessible medical care in the country. We are very pleased to be entering into this partnership with the formidable team of professionals at Jevremova.”

Vuk Vukovic, Partner at Blue Sea Capital, added: “We are very happy to continue our work with the management of both institutions, Dr Ristic, our first healthcare acquisition, and Jevremova, on the further development of the private health care sector in Serbia, and to support the expansion of the only private maternity ward in the country.”